drugset / Trial / NCT02704923

Atropine for Preventing Ventilator-Associated Pneumonia

NCT02704923

Phase 2 Completed 40 enrolled Universidade de Passo Fundo
RandomizedParallel-groupQuadruple-blindPrevention

Summary

A double-blind, placebo controlled trial of atropine eye drops used by sublingual way for preventing Ventilator-Associated Pneumonia.

Timeline

Start
2015-02
Primary completion
2015-12
Completion
2015-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atropine Other / unclassified 2 unknown Other

Indications

No indication recorded.